wcqualifiersasia| Watson Biotech: It is expected to continue to export finished PCV13 vaccine to Morocco this year

News summary

Watson Biotech: It is expected to continue to export finished PCV13 vaccine to Morocco this year. Securities Times Company News, Watson Biotech (300142) stated on the interactive platform on April 25 that the company will continue to export finished PCV13 vaccine to Morocco in 2024. This year's sales plan is inwcqualifiersasiaSome orders have arrivedwcqualifiersasia...

Newsletter text

Watson Biotech: It is expected to continue to export finished PCV13 vaccines to Morocco this year. Securities Times Company News, Watson Biotech (300142) stated on the interactive platform on April 25 that the company will continue to export finished PCV13 vaccines to Morocco in 2024. Some orders in this year's sales plan have arrived and revenue has been confirmed in the first quarter. At the same time, the company will continue to promote localized production in Morocco. Taking into account the number of local newborns and objective needs, it is expected that it will continue to export finished products to realize income this year. After Morocco partners complete the construction of localized production plants, they will continue to export raw liquids to meet local planned immunization needs.